Autres langues GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Temps réel estimé Cboe Europe Autres places de cotation 16:23:42 10/07/2026			Varia. 5j.	Varia. 1 janv.
1 963,75 ^GBX	+0,22%		-2,61%	+7,56%

14:12	GSK : le Ris-Rez atteint son critère d'évaluation principal dans un essai de phase 3 sur le cancer du poumon	AN
13:39	GSK : le traitement ciblé contre le cancer de Hansoh atteint son objectif principal de survie lors d'un essai en Chine	RE

Autres langues

14:12	GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
13:39	GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
13:34	GSK Licensor Hansoh Reports Positive Phase 3 Results for Risvutatug Rezetecan in China
13:32	GSK's Antibody-drug Conjugate for Small-cell Lung Cancer Meets Primary Endpoint in Late-stage China Study
13:10	GSK : licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population
09/07	Gsk plc Announces Appointment of Roy Jakobs to Non-Executive Director, Effective July 13, 2026
09/07	Afternoon Meeting: Wall Street ignora las alarmas
09/07	Wall Street Ignores the Sirens
09/07	GSK adds Royal Philips' Chief Executive Jakobs to board
09/07	CEO Philips in bestuur GSK
09/07	GSK : Roy Jakobs to join GSK Board as Non-Executive Director
09/07	Computacenter gets two price target hikes
09/07	Morning Meeting: El petróleo mantiene en vilo a los mercados
09/07	Öl hält die Märkte in Atem
09/07	Oil keeps markets on edge
09/07	UK Stocks-Factors to watch on July 9
08/07	European Stocks Close Sharply Lower in Wednesday Trading; Oil Prices Spike as US-Iran War Reignites
08/07	Trump durchkreuzt die Sommerruhe
08/07	Afternoon Meeting: Trump rompe la paz
08/07	Trump Breaks the Calm
08/07	GSK, Sino Biopharmaceutical Unit Expand Collaboration to Cover Two GSK Respiratory Therapies
08/07	European Midday Briefing : Shares Fall, Oil Rises as Trump Declares Ceasefire Over
08/07	UK Stocks-Factors to watch on July 8
08/07	Morning Meeting: Die Letzten werden die Ersten sein
08/07	Morning Meeting: Los últimos serán los primeros